本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kymera Therapeutics, Inc.

114.96
-2.0400-1.74%
盤後114.960.00000.00%19:30 EDT
成交量:57.42萬
成交額:6,617.17萬
市值:95.59億
市盈率:-35.79
高:119.93
開:118.40
低:113.74
收:117.00
52周最高:130.05
52周最低:45.84
股本:8,315.06萬
流通股本:6,487.46萬
量比:0.92
換手率:0.89%
股息:- -
股息率:- -
每股收益(TTM):-3.2122
每股收益(LYR):-3.6900
淨資產收益率:-24.15%
總資產收益率:-15.59%
市淨率:6.33
市盈率(LYR):-31.15

資料載入中...

2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/27

重要事件披露

Form 8-K - Current report
2026/03/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities